Literature DB >> 9477001

Drug discrimination analysis of pseudoephedrine in rats.

W Tongjaroenbuangam1, D Meksuriyen, P Govitrapong, N Kotchabhakdi, B A Baldwin.   

Abstract

Rats were trained to discriminate amphetamine, 1 mg/kg given intraperitoneally, from saline injection in a two-lever operant drug discrimination task. Pseudoephedrine (a sympathomimetic drug with central and peripheral actions) at doses of 10 mg/kg failed to substitute for amphetamine, at 20 mg/kg partial substitution occurred, while at a 40 mg/kg full substitution was seen. The specificity of the amphetamine cue at the training dose used (1 mg/kg) was shown by the finding that a peripherally acting sympathomimetic drug phenylephrine at doses from 0.2 to 0.8 mg/kg failed to substitute for amphetamine. The potential for abuse of pseudoephedrine administered at high doses is discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9477001     DOI: 10.1016/s0091-3057(97)00459-0

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  4 in total

1.  Effects of amphetamine-CNS depressant combinations and of other CNS stimulants in four-choice drug discriminations.

Authors:  Mi Li; William D Wessinger; D E McMillan
Journal:  J Exp Anal Behav       Date:  2005-07       Impact factor: 2.468

2.  Abuse-related effects of dual dopamine/serotonin releasers with varying potency to release norepinephrine in male rats and rhesus monkeys.

Authors:  Matthew L Banks; Clayton T Bauer; Bruce E Blough; Richard B Rothman; John S Partilla; Michael H Baumann; S Stevens Negus
Journal:  Exp Clin Psychopharmacol       Date:  2014-05-05       Impact factor: 3.157

3.  Self-administration of (+)-methamphetamine and (+)-pseudoephedrine, alone and combined, by rhesus monkeys.

Authors:  Kevin B Freeman; Zhixia Wang; William L Woolverton
Journal:  Pharmacol Biochem Behav       Date:  2010-01-25       Impact factor: 3.533

4.  Amphetamine and pseudoephedrine cross-tolerance measured by c-Fos protein expression in brains of chronically treated rats.

Authors:  Nootchanart Ruksee; Walaiporn Tongjaroenbuangam; Stefano O Casalotti; Piyarat Govitrapong
Journal:  BMC Neurosci       Date:  2008-10-06       Impact factor: 3.288

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.